![Dora Wang MD, MA](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/14054.jpg)
![Dora Wang MD, MA](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/14054.jpg)
Most Read This Week
- Comparative Cardiovascular Benefits of Bempedoic Acid and Statins
- Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in Individuals With Overweight/Obesity but Without Diabetes
- GLP-1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes
- Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation
- Effect of Semaglutide on Regression and Progression of Glycemia in Individuals With Overweight/Obesity but Without Diabetes
Recently Updated
- Irregular Sleep Duration Tied to Increased Risk for Developing Diabetes
- Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events
- Cutting Screen Use Boosts Mental Health in Children, Teens
- Mediterranean Diet Aids Cardiovascular Health Measures in Children, Teens
- Lack of Institutional Support May Drive Physician Reluctance to Address Addiction